Global Cannabis Market 2019-2024: Increasing Advances in Genetic Development and Intellectual Property of Cannabis

News provided by

Jun 27, 2019, 15:00 ET

DUBLIN, June 27, 2019 /PRNewswire/ -- The "Cannabis Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

The cannabis market was valued at USD 14.5 billion in 2018, and it is projected to reach 89.1 billion by 2024, with a CAGR of 37% during the forecast period.

The drivers identified in the market are medicinal properties of cannabis, increasing legalization of cannabis, and increasing advances in genetic development and intellectual property of cannabis.

The restraints identified in the market are illegal product in various countries, higher stress on water and sustainable agriculture, strict regulations against usage of cannabis, and strong competition with conventional treatment and traditional drugs.

Scope of the Report

Cannabis is a tall plant with a stiff upright stem, which is used as a drug and is being legalized for its medical usage. The report contains an analysis of the various parameters of the cannabis market. The study includes the major types of cannabis popular in the market and their market shares. The report presents wide-range analysis of the market share, size, and trends in the cannabis market. The market operates at B2C level, and market sizing has been done at the consumer level.

Key Market Trends

Increasing Legalization of Cannabis is Driving the Market

Medicinal cannabis accounts for the majority share of the cannabis market, when segmented on the basis of usage. Many countries have legalized the usage of cannabis for medicinal purposes. Many countries, where cannabis has been legalized, have a large adult population aged 50 and above. This increases the demand for medicinal cannabis, as the affinity of getting sick with chronic diseases increases after 50 years. Many countries, like the United States and Chile, have legalized the usage of cannabis for medicinal purposes; but the sale is illegal in these countries, and hence, cannabis is mostly donated between two organizations on a non-profit basis and strictly for usage in medical practices.

North America Dominates the Market

The cannabis market was valued at USD 14.5 billion in 2018 and it is projected to reach 89.1 billion by 2024, with a CAGR of 37% during the forecast period. The growth rate can be attributed to the fact that various countries are now legalizing the usage of cannabis for medical purposes and various states in the US are legalizing the usage of cannabis for recreational purposes as well. North America accounts for more than 95% of the cannabis market, with the US alone making up more than 90% share of the North American market.

Competitive Landscape

In the cannabis market, companies are very active and are constantly involved in acquiring shares and developing new products to attract a larger portion of consumers toward their products. Companies in the United States and Canada are focusing more on acquiring licenses for the production and trade of cannabis-based products. They are also involved in the development of food products containing cannabis, which is the preferred mode of consumption by the consumers.

Key Topics Covered:

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Introduction to Market Drivers and Restraints

4.3 Market Drivers

4.4 Market Restraints

4.5 Industry Attractiveness - Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 Usage

5.1.1 Medical

5.1.2 Recreational

5.2 Crop Variety

5.2.1 Cannabis Indica

5.2.2 Cannabis Sativa

5.2.3 Other Crop Varieties

5.3 Geography

6 COMPETITIVE LANDSCAPE

6.1 Most Adopted Competitor Strategies

6.2 Market Share Analysis

6.3 Company Profiles

6.3.1 Scotts Miracle-Gro Co.

6.3.2 Canopy Growth Corp.

6.3.3 GW Pharmaceuticals PLC

6.3.4 Aurora Cannabis Inc.

6.3.5 Aphria Inc.

6.3.6 MedReLeaf Corp.

6.3.7 Sprott Inc.

6.3.8 Insys Therapeutics Inc.

6.3.9 CanniMed Therapeutics Inc.

6.3.10 Cara Therapeutics Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit

https://www.researchandmarkets.com/r/gjr5dp

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets